颈动脉斑块脂质含量与纤维帽状态预测全身心血管结局:AIM-HIGH的MRI亚研究
在AIM-HIGH试验的MRI亚研究中,214例临床确诊动脉粥样硬化患者接受多对比颈动脉MRI,中位随访35.1个月,18例(8.4%)达到AIM-HIGH主要终点;斑块高脂质含量(每增加1个标准差,HR 1.57)和薄/破裂纤维帽(HR 4.31)与全身心血管结局强关联。
要点
- 颈动脉斑块高脂质核心体积百分比每增加1个标准差,AIM-HIGH终点风险HR 1.57(p=0.002)。
- 薄/破裂纤维帽与AIM-HIGH终点强关联,HR 4.31(p=0.003)。
- 斑块内出血患病率低(8%),与终点边缘关联HR 3.00(p=0.053)。
核心结论
- 在临床确诊动脉粥样硬化患者中,颈动脉斑块脂质含量和纤维帽状态与全身心血管结局强关联,斑块易损性标志物可能作为全身动脉血栓风险的替代标志物。
研究设计与样本
- AIM-HIGH事件驱动临床试验的MRI亚研究,232例受试者中214例(92.2%)图像质量合格纳入分析,采用多对比颈动脉MRI检测斑块组织成分和高危特征,参考标准为AIM-HIGH主要终点,采用Cox比例风险生存模型分析。
关键影像表现/征象
- 高脂质含量表现为脂质核心体积百分比增高,每增加1个标准差与AIM-HIGH终点相关(HR 1.57;p=0.002)。
- 薄/破裂纤维帽与AIM-HIGH终点强关联(HR 4.31;p=0.003)。
- 斑块内出血患病率8%,与AIM-HIGH终点边缘关联(HR 3.00;p=0.053)。
- 高钙化含量每增加1个标准差与AIM-HIGH终点无显著关联(HR 0.66;p=0.20)。
诊断标准与关键数值
- 高脂质含量定义为脂质核心体积百分比,每增加1个标准差HR 1.57(p=0.002)。
- 薄/破裂纤维帽HR 4.31(p=0.003)。
- 斑块内出血HR 3.00(p=0.053)。
- 高钙化含量每增加1个标准差HR 0.66(p=0.20)。
临床应用与阅片要点
- 在校正临床危险因素、斑块负荷或AIM-HIGH随机治疗分组后,颈动脉斑块特征与AIM-HIGH终点的关联变化很小。
- 斑块负荷指标和临床危险因素与AIM-HIGH终点无显著关联。
- 作者认为颈动脉斑块易损性标志物可能作为全身动脉血栓风险的替代标志物。
局限性
- 斑块内出血患病率低(8%),其与AIM-HIGH终点的关联仅为边缘性(HR 3.00;p=0.053)。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: The aim of this study was to investigate whether and what carotid plaque characteristics predict systemic cardiovascular outcomes in patients with clinically established atherosclerotic disease.
BACKGROUND: Advancements in atherosclerosis imaging have allowed assessment of various plaque characteristics, some of which are more directly linked to the pathogenesis of acute cardiovascular events compared to plaque burden.
METHODS: As part of the event-driven clinical trial AIM-HIGH (Atherothrombosis Intervention in Metabolic Syndrome with Low HDL/High Triglycerides: Impact on Global Health Outcomes), subjects with clinically established atherosclerotic disease underwent multicontrast carotid magnetic resonance imaging (MRI) to detect plaque tissue composition and high-risk features. Prospective associations between MRI measurements and the AIM-HIGH primary endpoint (fatal and nonfatal myocardial infarction, ischemic stroke, hospitalization for acute coronary syndrome, and symptom-driven revascularization) were analyzed using Cox proportional hazards survival models.
RESULTS: Of the 232 subjects recruited, 214 (92.2%) with diagnostic image quality constituted the study population (82% male, mean age 61 ± 9 years, 94% statin use). During median follow-up of 35.1 months, 18 subjects (8.4%) reached the AIM-HIGH endpoint. High lipid content (hazard ratio [HR] per 1 SD increase in percent lipid core volume: 1.57; p = 0.002) and thin/ruptured fibrous cap (HR: 4.31; p = 0.003) in carotid plaques were strongly associated with the AIM-HIGH endpoint. Intraplaque hemorrhage had a low prevalence (8%) and was marginally associated with the AIM-HIGH endpoint (HR: 3.00; p = 0.053). High calcification content (HR per 1 SD increase in percent calcification volume: 0.66; p = 0.20), plaque burden metrics, and clinical risk factors were not significantly associated with the AIM-HIGH endpoint. The associations between carotid plaque characteristics and the AIM-HIGH endpoint changed little after adjusting for clinical risk factors, plaque burden, or AIM-HIGH randomized treatment assignment.
CONCLUSIONS: Among patients with clinically established atherosclerotic disease, carotid plaque lipid content and fibrous cap status were strongly associated with systemic cardiovascular outcomes. Markers of carotid plaque vulnerability may serve as novel surrogate markers for systemic atherothrombotic risk.
引用
- Sun J, Zhao XQ, Balu N, et al. Carotid Plaque Lipid Content and Fibrous Cap Status Predict Systemic CV Outcomes: The MRI Substudy in AIM-HIGH. JACC Cardiovasc Imaging. 2017. PMID: 28279371. doi:10.1016/j.jcmg.2016.06.017
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。